Potent and selective ErbB receptor family inhibitor (IC50
values are 21, 22 and 38 nM for ErbB4, EGFR and ErbB2 respectively). Displays potent growth inhibition of human cancer cell lines overexpressing ErbB2 in vitro
= 60 - 168 nM) and inhibits growth of human tumor xenografts in vivo
. Brain penetrant and orally active.
Soluble to 50 mM in DMSO
Desiccate at +4°C
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Revoking the privilege: targeting HER2 in the central nervous system.
Contessa and Hamstra
Cellular and in vivo activity of JNJ-28871063, a nonquinazoline pan-ErbB kinase inhibitor that crosses the blood-brain barrier and displays efficacy against intracranial tumors.
Emanuel et al.
Signaling pathways in medulloblastoma.
Guessous et al.